News & Updates

Greater adherence to Mediterranean diet reduces CVD burden
Greater adherence to Mediterranean diet reduces CVD burden
11 Apr 2022
Seladelpar safe, effective for primary biliary cholangitis
Seladelpar safe, effective for primary biliary cholangitis
10 Apr 2022

In patients with primary biliary cholangitis, the use of seladelpar, a selective peroxisome proliferator-activated receptor-delta agonist, safely improves biochemical markers of cholestasis and inflammation, reports a new study.

Seladelpar safe, effective for primary biliary cholangitis
10 Apr 2022
Hepatitis B virus treatment rates still low among eligible patients
Hepatitis B virus treatment rates still low among eligible patients
10 Apr 2022